Uveitis in spondyloarthritis

J Rademacher, D Poddubnyy… - Therapeutic advances in …, 2020 - journals.sagepub.com
Uveitis is the most frequent extra-articular manifestation of axial spondyloarthritis (SpA),
occurring in up to one-third of the patients. In the majority of patients, uveitis is acute, anterior …

Pharmacologic treatment strategies in psoriatic arthritis

G Ayan, A Ribeiro, B Macit, F Proft - Clinical Therapeutics, 2023 - Elsevier
Purpose The goal of this narrative review was to provide current data on psoriatic arthritis
(PsA) therapeutic strategies, supporting treatment decisions with a domain-based approach …

[HTML][HTML] New pharmacological strategies for the treatment of non-infectious uveitis. a minireview

RA Valenzuela, I Flores, B Urrutia, F Fuentes… - Frontiers in …, 2020 - frontiersin.org
Non-infectious uveitis (NIU) is a group of disorders characterized by intraocular inflammation
at different levels of the eye. NIU is a leading cause of irreversible blindness in working-age …

The impact of certolizumab pegol treatment on the incidence of anterior uveitis flares in patients with axial spondyloarthritis: 48-week interim results from C-VIEW

I Van der Horst-Bruinsma, R Van Bentum… - RMD open, 2020 - rmdopen.bmj.com
Background Acute anterior uveitis (AAU) is the most common extra-articular manifestation in
patients with axial spondyloarthritis (axSpA). C-VIEW investigates the impact of the Fc-free …

The current status of biological treatment for uveitis

C Gaggiano, J Sota, S Gentileschi… - Expert Review of …, 2020 - Taylor & Francis
Introduction Noninfectious uveitis represents one of the leading causes of blindness in
developed Countries, compromising patients' quality of life and social functioning. The main …

Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet's syndrome

E Silvestri, A Bitossi, A Bettiol, G Emmi, ML Urban… - …, 2020 - Springer
Background To compare the efficacy of Adalimumab (ADA) in noninfectious anterior uveitis
(AU) and posterior segment (PS) involvement, associated with different conditions, with a …

[HTML][HTML] Pediatric uveitis: Role of the pediatrician

A Shivpuri, I Turtsevich, AL Solebo… - Frontiers in …, 2022 - frontiersin.org
The challenges of childhood uveitis lie in the varied spectrum of its clinical presentation, the
often asymptomatic nature of disease, and the evolving nature of the phenotype alongside …

[HTML][HTML] The role of biosimilars in uveitis: long-term real-world outcomes of the switch from original to biosimilar TNF-alpha inhibitors

C Fabiani, A Vitale, G Emmi, A Sgheri… - Frontiers in …, 2019 - frontiersin.org
Background: Recent expiry of patents for tumor necrosis factor (TNF)-α inhibitors has led to
the employment of biosimilars in clinical practice. The aim of the study was to identify any …

[HTML][HTML] Certolizumab Pegol treatment in patients with axial-Spondyloarthritis-associated acute anterior uveitis: a narrative review

IE van der Horst-Bruinsma, PC Robinson… - Rheumatology and …, 2022 - Springer
Background Acute anterior uveitis (AAU) affects up to 40% of patients with axial
spondyloarthritis (axSpA). An effective treatment for patients with axSpA that reduces the risk …

[PDF][PDF] Effectiveness of TNF-α blockade in the treatment of refractory non-infectious scleritis: a multicentre study

C Fabiani, J Sota, M Sainz-de-la-Maza… - Clin Exp …, 2020 - academia.edu
Effectiveness of TNF-α blockade in the treatment of refractory non-infectious scleritis: a
multicentre study Page 1 Clinical and Experimental Rheumatology 2020 Clinical and …